![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 25, 12384-12390, Sep, 1988
DA Engler, RK Matsunami, SR Campion, CD Stringer, A Stevens and SK Niyogi
A synthetic chimeric gene, coding for the human epidermal growth factor
fused to the signal peptide of Escherichia coli alkaline phosphatase, was
cloned into E. coli under the transcriptional control of the trp- lac (tac)
promoter. Following induction with isopropylthiogalactoside, the secretion
of the correctly processed protein product into the bacterial periplasm was
detected and quantitated by its specific binding to the epidermal growth
factor receptor. The purified protein was identical to authentic human
epidermal growth factor in size, amino acid composition, primary sequence,
receptor binding, and stimulation of receptor protein-tyrosine kinase
activity. Based on interspecies homologies, structural considerations, and
reported studies with peptide fragments, structure-function analysis was
initiated with alterations of targeted amino acid residues by
oligonucleotide-directed mutagenesis. The receptor binding affinity of each
mutant, relative to the wild type, was measured by both radioreceptor
competition and receptor tyrosine kinase stimulation assays. In general,
the values obtained by the two methods were in agreement for each species
of epidermal growth factor and followed the order: wild type greater than
Glu24----Gly greater than Asp27----Gly much greater than Pro7----Thr
greater than Tyr29----Gly greater than Leu47----His. The relatively low
values obtained with the last two mutants suggest that Tyr29 and Leu47 may
be important for the biological activity of human epidermal growth factor.
Cloning of authentic human epidermal growth factor as a bacterial secretory protein and its initial structure-function analysis by site- directed mutagenesis
Protein Engineering and Molecular Mutagenesis Program, Oak Ridge National Laboratory, Tennessee 37831-8077.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. S. Wiley, M. F. Woolf, L. K. Opresko, P. M. Burke, B. Will, J. R. Morgan, and D. A. Lauffenburger Removal of the Membrane-anchoring Domain of Epidermal Growth Factor Leads to Intracrine Signaling and Disruption of Mammary Epithelial Cell Organization J. Cell Biol., November 30, 1998; 143(5): 1317 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Toyoda, T. Komurasaki, D. Uchida, Y. Takayama, T. Isobe, T. Okuyama, and K. Hanada Epiregulin J. Biol. Chem., March 31, 1995; 270(13): 7495 - 7500. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mitamura, S. Higashiyama, N. Taniguchi, M. Klagsbrun, and E. Mekada Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity J. Biol. Chem., January 20, 1995; 270(3): 1015 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Swindle, K. T. Tran, T. D. Johnson, P. Banerjee, A. M. Mayes, L. Griffith, and A. Wells Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor J. Cell Biol., July 23, 2001; 154(2): 459 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Itoh, M. Kondo, Y. Tanaka, M. Kobayashi, R. Sasada, K. Igarashi, M. Suenaga, N. Koyama, O. Nishimura, and M. Fujino Novel Betacellulin Derivatives. SEPARATION OF THE DIFFERENTIATION ACTIVITY FROM THE MITOGENIC ACTIVITY J. Biol. Chem., October 26, 2001; 276(44): 40698 - 40703. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |